Biora Therapeutics Inc.

NASDAQ: PROG · Real-Time Price · USD
0.88
-0.04 (-3.96%)
At close: May 09, 2022, 6:00 AM

Biora Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-13.81M -92.87M -43.74M -78.53M -32.26M
Depreciation & Amortization
322K 373K 99K -284K 1.25M
Stock-Based Compensation
2.05M 2.4M 3.94M 3M 2.63M
Other Working Capital
-2.05M -23.54M -2.4M 10M -377K
Other Non-Cash Items
-7.1M 77.59M 5.3M 26.23M -16.73M
Deferred Income Tax
n/a n/a n/a n/a n/a
Change in Working Capital
-5.42M -27.54M -8.78M 13.9M -3.45M
Operating Cash Flow
-23.95M -40.05M -43.19M -35.69M -48.56M
Capital Expenditures
-342K n/a -2K -390K -463K
Cash Acquisitions
n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a 598K -430K -168K n/a
Investing Cash Flow
-342K 598K -432K -558K -463K
Debt Repayment
n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
3.13M 75.32M 31.77M 37.52M 22.23M
Financial Cash Flow
3.13M 75.32M 31.77M 37.52M 22.23M
Net Cash Flow
-21.16M 34.26M -11.86M 715K -26.8M
Free Cash Flow
-24.3M -40.05M -43.19M -36.08M -49.03M